Oncorus, Inc.
ONCRDelisted Jul 10, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001671818
Oncorus, Inc. was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Dec 30, 2022; 32 institutions reported holding it in 13F filings for Q1 2023, worth $3.78M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Oncorus, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 4 | 1 | −3 |
| Shares | 5.24M | 100 | −5.24M (−100.0%) |
| Value | $212.1K | $3 | −$212.1K (−100.0%) |
New holders (0)
Institutions that held Oncorus, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
None.
Sold out (3)
Institutions that held Oncorus, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| MPM Asset Management LLC | 2,849,464 | $115.4K |
| MPM Oncology Impact Management LP | 2,377,031 | $96.3K |
| Barclays PLC | 9,495 | $384 |